Trial intelligence / Profile preview

Vildagliptin for Vascular Function in Insulin Resistance

NCT01122641Phase 3Completed

Sponsor
Royal Devon University Healthcare NHS Foundation Trust
Start
May 2010
Primary completion
Aug 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of vildagliptin in insulin resistance (IR), sponsored by Royal Devon University Healthcare NHS Foundation Trust. Started May 2010; status: completed.

02

Drugs

vildagliptin
03

Conditions

insulin resistance (IR)

Beyond the preview

Go deeper on NCT01122641.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01122641.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call